Reduced red blood cell deformability, an indicator for high fetal or maternal risk, is found in preeclampsia and IUGR

B Schauf1, U Lang, P Stute

  • 1Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany. burkhard.schauf@med.uni-tuebingen.de

Insights

Red blood cell (RBC) deformability is reduced in pregnancies with preeclampsia (PE) and intrauterine growth restriction (IUGR), potentially impacting microcirculation. Therapeutic increases in RBC deformability may improve fetal perfusion.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Perinatology

Background:

  • Red blood cell (RBC) deformability is crucial for microcirculation.
  • Preeclampsia (PE) and intrauterine growth restriction (IUGR) are associated with reduced microcirculation.
  • Understanding RBC deformability in these conditions is vital for maternal and fetal health.

Purpose of the Study:

  • To compare RBC deformability in uncomplicated pregnancies versus those with PE and/or IUGR.
  • To investigate changes in RBC deformability throughout gestation and postpartum.
  • To assess the relationship between RBC deformability and pregnancy complications.

Main Methods:

  • Evaluated RBC deformability using a laser diffractoscope in 87 pregnant women and 10 nonpregnant women.
  • Measurements were taken from week 16 of gestation up to 5 days postpartum.
  • Included groups with uncomplicated pregnancy, PE, IUGR, and combined PE/IUGR.

Main Results:

  • RBC deformability in early uncomplicated pregnancies matched nonpregnant levels.
  • A slight decrease in RBC deformability was observed around week 30 of gestation in uncomplicated pregnancies.
  • Women with PE and/or IUGR exhibited significantly reduced RBC deformability, most severe in complicated cases.

Conclusions:

  • Reduced RBC deformability may contribute to impaired microcirculation in PE and IUGR.
  • Therapeutic enhancement of RBC deformability could be a novel treatment strategy.
  • This approach may improve uterine and fetal perfusion and mitigate related complications.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...